Magnetic resonance imaging

Active Ingredient: Gadopiclenol

Indication for Gadopiclenol

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Gadopiclenol is for diagnostic use only.

Gadopiclenol is indicated in adults and children aged 2 years and older for contrast-enhanced magnetic resonance imaging (MRI) to improve detection and visualization of pathologies with disruption of the blood-brain-barrier (BBB) and/or abnormal vascularity of:

  • the brain, spine, and associated tissues of the central nervous system (CNS);
  • the liver, kidney, pancreas, breast, lung, prostate, and musculoskeletal system.

It should be used only when diagnostic information is essential and not available with unenhanced MRI.

For this indication, competent medicine agencies globally authorize below treatments:

0.05 mmol/kg body weight

For:

Dosage regimens

In case that patient age in years is ≥ 2, intravenous, 0.05 moles gadopiclenol per kilogram of body weight, one dose.

Detailed description

The recommended dose is 0.05 mmol/kg body weight (BW) to provide diagnostically adequate contrast for all indications.

The dose should be calculated based on the patient’s BW and should not exceed the recommended dose per kilogram of BW detailed in this section.

Paediatric population (2 years and older)

The recommended and maximum dose is 0.05 mmol/kg BW for all indications. More than one dose should not be used during a scan.

Elderly

No dose adjustment is necessary. Caution should be exercised in elderly patients.

Image acquisition

Contrast-enhanced MRI can start after the injection depending on the pulse sequences used and the protocol for the examination. Optimal signal enhancement is generally observed during arterial phase and within a period of about 15 minutes after injection. Longitudinal relaxation times (T1)-weighted sequences are particularly suitable for contrast-enhanced examinations.

Dosage considerations

Intravenous administration of contrast agent should, if possible, be done with the patient lying down. Since experience shows that most undesirable effects occur within minutes after administration, the patient should be kept under observation during and following administration for at least half an hour.

Active ingredient

Gadopiclenol

Gadopiclenol is a paramagnetic agent for Magnetic Resonance Imaging (MRI). The contrast-enhancing effect is mediated by gadopiclenol which is a macrocyclic non-ionic complex of gadolinium, the active moiety which enhances the relaxation rates of water protons in its vicinity in the body, leading to an increase in signal intensity (brightness) of tissues.

Read more about Gadopiclenol

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.